Netherlands - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Care Payment Schemes
Since 2014, Netherlands Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Care Payment Schemes fell by 18.4% year on year. With €1.41 Per Capita in 2019, the country was number 17 among other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Care Payment Schemes. Netherlands is overtaken by Estonia, which was number 16 at €1.58 Per Capita and is followed by Germany at €0.98 Per Capita. Slovenia ranked the highest with €84.89 Per Capita in 2019, -0.2% versus 2018. Switzerland, Iceland and France respectively ranked number 2, 3 and 4 in this ranking. Estonia recorded the best 5 years average growth at +92.4% per year, while Romania recorded the worst performance at -29.3% per year.
Loading...
Date | Euros Per Capita |
---|---|
2019 | 1.41 |
2018 | 3.60 |
2017 | 3.68 |
2016 | 3.93 |
2015 | 4.30 |
How does Netherlands rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Voluntary Health Care Payment Schemes?
# | 22 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Slovenia
|
84.89 | 2019 | -0.2 % | +2.2 % | View data | |
2 |
#2
Switzerland
|
71.28 | 2019 | -9.9 % | +18.2 % | View data | |
16 |
#16
Estonia
|
1.58 | 2019 | -23.7 % | +92.3 % | View data | |
17 |
#17
Netherlands
|
1.41 | 2019 | -60.8 % | -18.4 % | View data | |
18 |
#18
Germany
|
0.98 | 2019 | -53.8 % | -12.5 % | View data |